MYND - MYnd Analytics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.72
-0.17 (-8.99%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.89
Open1.88
Bid1.68 x 800
Ask2.18 x 900
Day's Range1.68 - 1.98
52 Week Range1.15 - 5.05
Volume235,243
Avg. Volume453,975
Market Cap10.809M
Beta0.37
PE Ratio (TTM)N/A
EPS (TTM)-2.28
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.00
Trade prices are not sourced from all markets
  • GlobeNewswire16 hours ago

    MYnd Analytics to Provide TeleEAP Services for Integrated Behavioral Health, a National Managed Behavioral Health Company

    MISSION VIEJO, Calif., Sept. 20, 2018-- MYnd Analytics, Inc., a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, ...

  • GlobeNewswire3 days ago

    MYnd Analytics Announces Nationwide Expansion of Telepsychiatry & Telebehavioral Health Services for Leading EAP Provider Claremont Behavioral Services

    MYnd Analytics, Inc. (MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that its wholly owned subsidiary, Arcadian Telepsychiatry Services LLC, has expanded its relationship with Claremont Behavioral Services Inc, a leading provider of Employee Assistance Programs (EAP).  Under the new agreement, Arcadian will provide Claremont’s members and employees outside of California with nationwide services through its provider network following a successful pilot program.

  • GlobeNewswire4 days ago

    FDA Designates Breakthrough Device Status for MYnd Analytics’ PEER 4.0

    MYnd Analytics, Inc. (MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics with augmented intelligence, today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Device designation for the Company’s next generation product PEER 4.0. PEER (the Psychiatric EEG Evaluation Registry) is the company's proprietary clinical phenotype database comprising over 40,000 medication outcomes for over 11,000 unique patients, which is used to predict how a patient will respond to a specific medication.

  • GlobeNewswire8 days ago

    MYnd Analytics Partners with Sanford Health to Provide Telepsychiatry Services Supporting Outpatient Primary Care Practices

    MISSION VIEJO, Calif., Sept. 13, 2018-- MYnd Analytics, Inc., a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, ...

  • GlobeNewswire10 days ago

    MYnd Analytics and Arcadian Telepsychiatry Services Announce Launch of Correctional Facilities Telepsychiatry Program; Designed to Provide Inmates Improved Access to Mental Health Services

    MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that its wholly owned subsidiary, Arcadian Telepsychiatry Services LLC, has launched a new program to offer, through its network of providers, inmates of correctional facilities with access to telepsychiatry, teletherapy and other mental health services. Telepsychiatry involves the use of video conferencing equipment to conduct real time mental health consultations between a clinician and a patient.

  • GlobeNewswire15 days ago

    Publication Demonstrates the Potential Positive Economic Impact to Payors and Self-insured Employers if Doctors Utilize MYnd Analytics’ PEER™

    MYnd Analytics, Inc. (MYND), a market leader in improving the delivery of mental health treatment through the combination of telemedicine and data analytics/augmented intelligence, announced today the publication of an article entitled, “A Promising New Strategy to Improve Treatment Outcomes for Patients with Depression,” in Population Health Management, a leading peer-reviewed journal focused on improving health outcomes.  The article highlights the positive economic impact to payors and self-insured employers when the Company’s Psychiatric EEG Evaluation Registry (PEER) is utilized to inform therapeutic choices, including a 4.7 to 1 cost offset by reducing “trial-and-error” treatment. The Population Health Management article follows recently published results of the EMBARC trial (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) in the JAMA (Journal of the American Medical Association) Psychiatry in June 2018, which found that measuring electrical activity in the brain through the non-invasive EEG test can help predict a patient's response to an antidepressant.  EMBARC was a multicenter trial, funded by the National Institute of Mental Health, involving researchers at Harvard Medical School and Massachusetts General Hospital, Columbia University, McLean Hospital, Stanford University, University of Pittsburgh, and the University of Michigan.

  • GlobeNewswire22 days ago

    MYnd Analytics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City

    MYnd Analytics, Inc. (MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, announced today that it will be presenting at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 4-6, 2018 at The St. Regis New York in New York City. George Carpenter, Chief Executive Officer of MYnd Analytics, will provide an overview of the Company’s business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. If you are an institutional investor, and would like to attend the Company’s presentation, please click on the follow link (www.rodmanevents.com) to register for the Rodman & Renshaw conference.

  • ACCESSWIRE29 days ago

    Today’s Research Reports on Stocks to Watch: MYnd Analytics and Exact Sciences

    NEW YORK, NY / ACCESSWIRE / August 23, 2018 / Exact Sciences made headlines on Wednesday, announcing an agreement with Pfizer to share marketing expenses and to co-promote the company’s Colorguard colorectal ...

  • GlobeNewswire29 days ago

    MYnd Analytics and Arcadian Telepsychiatry Services Announce Partnership with Employee Assistance Network, Inc. to Provide Tele-EAP Services

    Under the agreement, Arcadian will provide tele-EAP services for EAN’s customers through its provider network. An EAP is a program designed to provide confidential and professional assistance to help resolve issues that affect employees and their families.

  • GlobeNewswirelast month

    MYnd Analytics Invited to Present at the 2018 Military Health System Research Symposium

    The MHSRS is the only military or civilian meeting that focuses specifically on the unique medical needs of the soldier. The MHSRS is an annual four-day educational symposium that draws approximately 2,300 attendees.

  • GlobeNewswirelast month

    MYnd Analytics Partners with Inova Mount Vernon Hospital to Improve Mental Health Outcomes

    MYnd Analytics, Inc. (MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced an agreement to provide neuropsychiatric testing for the Inova Health System (Inova), a global leader in personalized health serving more than 2 million people each year across the Washington, DC, metro area and beyond.  The program will begin with Inova’s Mount Vernon Hospital, where PEER testing will be provided for psychiatric outpatient and inpatient services.

  • GlobeNewswirelast month

    MYnd Analytics Provides Business Update for the Third Quarter of 2018

    MYnd Analytics, Inc. (MYND) (“MYnd” or the “Company”), a market leader in improving the delivery of mental health services and reducing costs through the combination of telemedicine and data analytics/artificial (augmented) intelligence, today provided a business update and reported financial results for the fiscal third quarter and nine months ended June 30, 2018. Arcadian is partnering with schools, community organizations, hospitals, assisted living and skilled nursing facilities, as well as other institutions, to rapidly deploy the telemedicine platform across its customers’ respective organizations.  Revenue for the three months ended June 30, 2018 increased to approximately $392,000, compared to $40,400 for the same period ended June 30, 2017.  Net loss for the fiscal third quarter of 2018 was approximately $2.9 million, which included $742,000 of non-cash expenses, compared to net loss of approximately $1.6 million for the same period last year.  The Company raised approximately $5.0 million in cash during the nine months ended June 30, 2018 and ended the fiscal third quarter of 2018 with $2.6 million in cash and cash equivalents.

  • GlobeNewswire2 months ago

    MYnd Analytics Partners with VisionQuest to Provide Telepsychiatry Services for its Community-Based Outpatient Mental Health Clinic in Pennsylvania

    MYnd Analytics, Inc. (MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that its wholly owned subsidiary, Arcadian Telepsychiatry Services LLC, has partnered with VisionQuest, to provide telepsychiatry services through Arcadian’s provider network for LodgeQuest, VisionQuest’s community-based, outpatient mental health clinic in Chambersburg, Pennsylvania.  VisionQuest is a national organization that serves thousands of youths each year. According to the American Psychological Association, approximately one out of every five children in America has a diagnosable mental health disorder, and mental health problems in young people are associated with outcomes such as suicide, substance use, inability to live independently, justice involvement, school dropout, economic hardship and physical health problems.  Additionally, the American Psychological Association reports that less than half of the children with mental health problems get treatment, services or support, due to lack of access to needed mental health and substance use services, and only one in five get treatment from a mental health worker with special training to work with children.

  • GlobeNewswire2 months ago

    MYnd Analytics and Arcadian Telepsychiatry Services Launch Comprehensive Behavioral Health Solution for Skilled Nursing and Assisted Living Facilities

    The new program provides patients of skilled nursing and assisted living facilities with access to telepsychiatry, teletherapy and other mental health services. Telepsychiatry involves the use of video conferencing equipment to conduct real-time mental health consultations between a clinician and a patient.

  • Is MYnd Analytics Inc (NASDAQ:MYND) A Financially Sound Company?
    Simply Wall St.3 months ago

    Is MYnd Analytics Inc (NASDAQ:MYND) A Financially Sound Company?

    Investors are always looking for growth in small-cap stocks like MYnd Analytics Inc (NASDAQ:MYND), with a market cap of US$12.38m. However, an important fact which most ignore is: how financiallyRead More...

  • Who Owns Most Of MYnd Analytics Inc (NASDAQ:MYND)?
    Simply Wall St.4 months ago

    Who Owns Most Of MYnd Analytics Inc (NASDAQ:MYND)?

    In this article, I will take a quick look at MYnd Analytics Inc’s (NASDAQ:MYND) recent ownership structure – an unconventional investing subject, but an important one. The impact of aRead More...

  • Breakeven On The Horizon For MYnd Analytics Inc (NASDAQ:MYND)
    Simply Wall St.5 months ago

    Breakeven On The Horizon For MYnd Analytics Inc (NASDAQ:MYND)

    MYnd Analytics Inc’s (NASDAQ:MYND): MYnd Analytics, Inc. operates as a predictive analytics company primarily in the United States. The company’s loss has recently broadened since it announced a -US$7.11M lossRead More...

  • ACCESSWIRE5 months ago

    MYnd Analytics, Adding AI in Telemedicine, Analyst Report and Market Outlook

    NEW YORK, NY / ACCESSWIRE / April 17, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...

  • What does MYnd Analytics Inc’s (NASDAQ:MYND) Balance Sheet Tell Us About Its Future?
    Simply Wall St.5 months ago

    What does MYnd Analytics Inc’s (NASDAQ:MYND) Balance Sheet Tell Us About Its Future?

    Investors are always looking for growth in small-cap stocks like MYnd Analytics Inc (NASDAQ:MYND), with a market cap of US$5.50M. However, an important fact which most ignore is: how financiallyRead More...

  • MYnd Analytics Inc (NASDAQ:MYND): Should The Recent Earnings Drop Worry You?
    Simply Wall St.6 months ago

    MYnd Analytics Inc (NASDAQ:MYND): Should The Recent Earnings Drop Worry You?

    For long-term investors, assessing earnings trend over time and against industry benchmarks is more beneficial than examining a single earnings announcement at a point in time. Investors may find myRead More...